187 related articles for article (PubMed ID: 19299075)
21. [Silencing of vacuolar ATPase c subunit ATP6V0C inhibits invasion of prostate cancer cells].
Zou PC; Yang YF; Xu XY; Liu BY; Mei F; You JF; Liu QC; Pei F
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):937-947. PubMed ID: 29263462
[TBL] [Abstract][Full Text] [Related]
22. A novel tumor metastasis suppressor gene LASS2/TMSG1 interacts with vacuolar ATPase through its homeodomain.
Yu W; Wang L; Wang Y; Xu X; Zou P; Gong M; Zheng J; You J; Wang H; Mei F; Pei F
J Cell Biochem; 2013 Mar; 114(3):570-83. PubMed ID: 22991218
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
24. A cytotoxic type III secretion effector of Vibrio parahaemolyticus targets vacuolar H+-ATPase subunit c and ruptures host cell lysosomes.
Matsuda S; Okada N; Kodama T; Honda T; Iida T
PLoS Pathog; 2012; 8(7):e1002803. PubMed ID: 22829766
[TBL] [Abstract][Full Text] [Related]
25. Regulation of growth hormone secretion by (pro)renin receptor.
Tani Y; Yamada S; Inoshita N; Hirata Y; Shichiri M
Sci Rep; 2015 Jun; 5():10878. PubMed ID: 26039928
[TBL] [Abstract][Full Text] [Related]
26. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
Chang L; Hu Z; Zhou Z; Zhang H
Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
[TBL] [Abstract][Full Text] [Related]
27. Silencing of a novel tumor metastasis suppressor gene LASS2/TMSG1 promotes invasion of prostate cancer cell in vitro through increase of vacuolar ATPase activity.
Xu X; You J; Pei F
J Cell Biochem; 2012 Jul; 113(7):2356-63. PubMed ID: 22573553
[TBL] [Abstract][Full Text] [Related]
28. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance.
Wang S; Yang Y; Wang Y; Chen M
Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923
[TBL] [Abstract][Full Text] [Related]
29. Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells.
Hrabeta J; Groh T; Khalil MA; Poljakova J; Adam V; Kizek R; Uhlik J; Doktorova H; Cerna T; Frei E; Stiborova M; Eckschlager T
Int J Oncol; 2015 Sep; 47(3):971-80. PubMed ID: 26134421
[TBL] [Abstract][Full Text] [Related]
30. TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells.
Lozupone F; Borghi M; Marzoli F; Azzarito T; Matarrese P; Iessi E; Venturi G; Meschini S; Canitano A; Bona R; Cara A; Fais S
Oncogene; 2015 Oct; 34(40):5163-74. PubMed ID: 25659576
[TBL] [Abstract][Full Text] [Related]
31. HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response.
Liu X; Yu Y; Zhang J; Lu C; Wang L; Liu P; Song H
Cell Physiol Biochem; 2018; 48(4):1505-1518. PubMed ID: 30071534
[TBL] [Abstract][Full Text] [Related]
32. The a3 isoform of subunit a of the vacuolar ATPase localizes to the plasma membrane of invasive breast tumor cells and is overexpressed in human breast cancer.
Cotter K; Liberman R; Sun-Wada G; Wada Y; Sgroi D; Naber S; Brown D; Breton S; Forgac M
Oncotarget; 2016 Jul; 7(29):46142-46157. PubMed ID: 27323815
[TBL] [Abstract][Full Text] [Related]
33. Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma.
Emruli VK; Olsson R; Ek F; Ek S
BMC Cancer; 2016 Jul; 16():493. PubMed ID: 27430213
[TBL] [Abstract][Full Text] [Related]
34. [Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA].
Li CB; Zhang F; Shi YR; Wei XY; Yang Y; Niu RF
Ai Zheng; 2004 Dec; 23(12):1605-10. PubMed ID: 15601546
[TBL] [Abstract][Full Text] [Related]
35. [Silencing of tumor metastasis suppressor gene 1 promotes invasion of prostate cancer cell in vitro and its molecular mechanisms].
Xu XY; You JF; Pei F; Zhang B
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):814-9. PubMed ID: 22178826
[TBL] [Abstract][Full Text] [Related]
36. Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H⁺)-ATPase Inhibitors.
Patil R; Kulshrestha A; Tikoo A; Fleetwood S; Katara G; Kolli B; Seibel W; Gilman-Sachs A; Patil SA; Beaman KD
Molecules; 2017 Sep; 22(9):. PubMed ID: 28926955
[TBL] [Abstract][Full Text] [Related]
37. V-ATPase as an effective therapeutic target for sarcomas.
Perut F; Avnet S; Fotia C; Baglìo SR; Salerno M; Hosogi S; Kusuzaki K; Baldini N
Exp Cell Res; 2014 Jan; 320(1):21-32. PubMed ID: 24416789
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
[TBL] [Abstract][Full Text] [Related]
39. Cancer with low cathepsin D levels is susceptible to vacuolar (H
Kitazawa S; Nishizawa S; Nakagawa H; Funata M; Nishimura K; Soga T; Hara T
Cancer Sci; 2017 Jun; 108(6):1185-1193. PubMed ID: 28317223
[TBL] [Abstract][Full Text] [Related]
40. Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer.
Hernandez A; Serrano-Bueno G; Perez-Castineira JR; Serrano A
Curr Pharm Des; 2012; 18(10):1383-94. PubMed ID: 22360554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
